These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16940110)

  • 1. Antibiotic-induced enterococcal expansion in the mouse intestine occurs throughout the small bowel and correlates poorly with suppression of competing flora.
    Lakticová V; Hutton-Thomas R; Meyer M; Gurkan E; Rice LB
    Antimicrob Agents Chemother; 2006 Sep; 50(9):3117-23. PubMed ID: 16940110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antienterococcal activity explains associations between exposures to antimicrobial agents and risk of colonization by multiresistant enterococci.
    Rice LB; Lakticová V; Helfand MS; Hutton-Thomas R
    J Infect Dis; 2004 Dec; 190(12):2162-6. PubMed ID: 15551215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of parenteral antibiotic administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract.
    Donskey CJ; Hanrahan JA; Hutton RA; Rice LB
    J Infect Dis; 1999 Aug; 180(2):384-90. PubMed ID: 10395853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of parenteral antibiotic administration on the establishment of colonization with vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract.
    Donskey CJ; Hanrahan JA; Hutton RA; Rice LB
    J Infect Dis; 2000 May; 181(5):1830-3. PubMed ID: 10823795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotics and gastrointestinal colonization by vancomycin-resistant enterococci.
    Rice LB
    Eur J Clin Microbiol Infect Dis; 2005 Dec; 24(12):804-14. PubMed ID: 16362383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the increasing use of piperacillin/tazobactam on the incidence of vancomycin-resistant enterococci in four academic medical centers.
    Stiefel U; Paterson DL; Pultz NJ; Gordon SM; Aron DC; Donskey CJ
    Infect Control Hosp Epidemiol; 2004 May; 25(5):380-3. PubMed ID: 15188842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a formulary switch from ticarcillin-clavulanate to piperacillin-tazobactam on colonization with vancomycin-resistant enterococci.
    Winston LG; Charlebois ED; Pang S; Bangsberg DR; Perdreau-Remington F; Chambers HF
    Am J Infect Control; 2004 Dec; 32(8):462-9. PubMed ID: 15573053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
    Nomura S; Hanaki H; Nagayama A
    J Chemother; 1997 Apr; 9(2):89-94. PubMed ID: 9176745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of bovine lactoferrin on the MICs of ampicillin/sulbactam (UNASYN), amoxicillin/clavulanic acid (Augmentin), ticarcillin clavulanate (Timentin), and piperacillin-tazobactam (ZOSYN), against clinical and environmental isolates of motile Aeromonas.
    WaKabongo M; Stucki ZN; Torbert DP; Olweny J
    J Am Osteopath Assoc; 2005 Jan; 105(1):25-6. PubMed ID: 15710671
    [No Abstract]   [Full Text] [Related]  

  • 10. Beta-lactam antibiotics and gastrointestinal colonization with vancomycin-resistant enterococci.
    Rice LB; Hutton-Thomas R; Lakticova V; Helfand MS; Donskey CJ
    J Infect Dis; 2004 Mar; 189(6):1113-8. PubMed ID: 14999616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS; Tosin I; Sejas L; Miranda E
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro activity of beta-lactam/beta-lactamase inhibitor combinations against gram negative bacteria.
    Mohanty S; Singhal R; Sood S; Dhawan B; Das BK; Kapil A
    Indian J Med Res; 2005 Nov; 122(5):425-8. PubMed ID: 16456257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic-Driven Dysbiosis Mediates Intraluminal Agglutination and Alternative Segregation of Enterococcus faecium from the Intestinal Epithelium.
    Hendrickx AP; Top J; Bayjanov JR; Kemperman H; Rogers MR; Paganelli FL; Bonten MJ; Willems RJ
    mBio; 2015 Nov; 6(6):e01346-15. PubMed ID: 26556272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transferable capacity for gastrointestinal colonization in Enterococcus faecium in a mouse model.
    Rice LB; Lakticová V; Carias LL; Rudin S; Hutton R; Marshall SH
    J Infect Dis; 2009 Feb; 199(3):342-9. PubMed ID: 19049434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
    Rudy M; Nowakowska M; Wiechuła B; Zientara M; Radosz-Komoniewska H
    Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased susceptibility to vancomycin-resistant Enterococcus intestinal colonization persists after completion of anti-anaerobic antibiotic treatment in mice.
    Stiefel U; Pultz NJ; Helfand MS; Donskey CJ
    Infect Control Hosp Epidemiol; 2004 May; 25(5):373-9. PubMed ID: 15188841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms by which anaerobic microbiota inhibit the establishment in mice of intestinal colonization by vancomycin-resistant Enterococcus.
    Pultz NJ; Stiefel U; Subramanyan S; Helfand MS; Donskey CJ
    J Infect Dis; 2005 Mar; 191(6):949-56. PubMed ID: 15717271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of vancomycin-resistant Enterococcus faecium gastrointestinal tract colonization in antibiotic-treated mice.
    Dever LL; Handwerger S
    Microb Drug Resist; 1996; 2(4):415-21. PubMed ID: 9158812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative activities of cefepime and piperacillin/tazobactam tested against a global collection of Escherichia coli and Klebsiella spp. with an ESBL phenotype.
    Sader HS; Hsiung A; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2007 Mar; 57(3):341-4. PubMed ID: 17141461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative bacteriostatic activity of ticarcillin, alone and combined with clavulanic acid, 5 cephalosporins and metronidazole against 100 strains of Bacteroides fragilis].
    de Barbeyrac B; Quentin C; Bebear C
    Pathol Biol (Paris); 1984 May; 32(5):433-5. PubMed ID: 6739151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.